Trademark Overview
On Wednesday, October 29, 2025, a trademark application was filed for BIODYSSEY with the United States Patent and Trademark Office. The USPTO has given the BIODYSSEY trademark a serial number of 99468511. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, May 20, 2026. This trademark is owned by Biodyssey Therapeutics, Inc.. The BIODYSSEY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific research; Scientific research and development in the fields of oncology, radiopharmaceuticals, and cancer treatment; Pharmaceutical research and development of new radiopharmaceutical agents; Design and testing of radiopharmaceutical drugs for cancer diagnosis and therapy for others; Laboratory research and testing in the field of nuclear medicine and targeted radiotherapy; research laboratory analysis services in the field of nuclear medicine and targeted radiotherapy; Providing scientific information in the field of biochemistry, biotechnology, pharmaceutical research and development, and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
Pharmaceutical preparations for the treatment of cancer in the nature of anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations for cancer treatment; diagnostic radiopharmaceutical preparations for clinical, medical and research use for treating cancer